美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

艾格里房产

66.17

+0.22000.33%

盘后：66.300.1300+0.20%19:59 EDT

成交量：265.36万

成交额：1.75亿

市值：82.30亿

市盈率：35.74

高：66.32

开：65.97

低：65.62

收：65.95

52周最高：82.08

52周最低：64.43

股本：1.24亿

流通股本：1.22亿

量比：1.56

换手率：2.17%

股息：3.14

股息率：4.75%

每股收益(TTM):1.85

每股收益(LYR):1.77

净资产收益率：3.70%

总资产收益率：2.40%

市净率：1.30

市盈率(LYR):37.38

数据加载中...

总览公司新闻资讯公告

百利天恒：双抗ADC药物非小细胞肺癌III期临床达主要终点

博安生物(06955)：BA1302 (CD228 ADC)完成中国Ia期临床研究

艾力斯医药获得ArriVent潜在全球首创ADC权益；京东健康上半年累计首发65款新药 | 医药早参

每日经济新闻

第一三共/阿斯利康(AZN.US)重磅ADC药物“德曲妥珠单抗”又一项新适应症在中国获批上市

优赫得联合帕妥珠单抗在华获批HER2阳性转移性乳腺癌一线治疗，成为十余年来该领域首个获批的创新ADC方案

【券商聚焦】招商证券首予映恩生物（09606）强烈推荐评级指ADC管线差异化优势显著

ADC的矿源耗竭了吗？

百济神州：公司拟披露CEA ADC在非小细胞肺癌中的早期数据，覆盖鳞癌和非鳞癌患者

再鼎医药2026 Q2产品环比收入增长11%，DLL3 ADC最快明年提交美国上市申请

港股异动 | 科伦博泰生物(06990)午前涨超4% 新型双载荷ADC药物SKB565新药临床试验申请获批

22亿美元ADC出海改写康宁杰瑞

国际金融报

港股异动 | 百奥赛图-B(02315)涨超10% 双抗ADC推进海外开发临床前CRO与模型鼠景气度上行

康宁杰瑞制药-B早盘涨超12% TROP2/HER3双抗ADC授权出海

中国生物制药(01177)：TQB2102“HER2双抗ADC”第三次被CDE纳入突破性治疗药物名单

港股异动 | 百奥赛图-B(02315)午后涨超8% 近期与Whitehawk达成合作旗下5款双抗ADC出海

智通财经网

李氏大药厂：专有ADC项目ZK2401新药临床试验申请获NMPA受理

科伦药业(002422.SZ)：TROP2 ADC芦康沙妥珠单抗(sac-TMT)新增适应症上市申请获受理

Sonesitatug vedotin 在 CLDN18.2阳性晚期胃癌/胃食管结合部癌的二线及后线治疗中，显示出具有统计学显著性且重要临床意义的总生存期（OS）改善

科伦药业(002422.SZ)：科伦博泰新型双载荷ADC药物SKB565新药临床试验(IND)申请获批

英派药业首个双载荷ADC成果落地：IMP3201被提名为临床前候选化合物

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/ADC/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"艾格里房产","latestPrice":66.17,"timestamp":1791835200000,"preClose":65.95,"halted":0,"volume":2653642,"hourTrading":{"tag":"盘后","latestPrice":66.3,"preClose":66.17,"latestTime":"19:59 EDT","volume":619066,"amount":40963636.88,"timestamp":1791849545698,"change":0.13,"changeRate":0.001965,"amplitude":0.001965},"delay":0,"changeRate":0.0033358605003790576,"floatShares":122178283,"shares":124379300,"eps":1.85165,"marketStatus":"未开盘","change":0.22,"latestTime":"10-12 16:00:00 EDT","open":65.97,"high":66.32,"low":65.62,"amount":175412333.154012,"amplitude":0.010614,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.85165,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791878400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":65.95,"dividendRate":0.047469,"preHourTrading":{"tag":"盘前","latestPrice":65.95,"preClose":65.95,"latestTime":"09:29 EDT","volume":345,"amount":22797.08733,"timestamp":1791811786075,"change":0,"changeRate":0,"amplitude":0.042399},"postHourTrading":{"tag":"盘后","latestPrice":66.3,"preClose":66.17,"latestTime":"19:59 EDT","volume":619066,"amount":40963636.88,"timestamp":1791849545698,"change":0.13,"changeRate":0.001965,"amplitude":0.001965},"volumeRatio":1.56257,"impliedVol":0.2558,"impliedVolPercentile":0.8367},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","floatShares":122178283,"roa":"2.40%","roe":"3.70%","lyrEps":1.77,"volumeRatio":1.56257,"shares":124379300,"dividePrice":3.141,"high":66.32,"amplitude":0.010614,"preClose":65.95,"low":65.62,"week52Low":64.43,"pbRate":"1.30","psRate":"10.56","week52High":82.08,"institutionHeld":0.85,"latestPrice":66.17,"eps":1.85165,"divideRate":0.047469,"volume":2653642,"delay":0,"ttmEps":1.85165,"open":65.97,"prevYearClose":72.03,"prevWeekClose":65.95,"prevMonthClose":66.81,"prevQuarterClose":66.81,"fiveDayClose":65.58,"twentyDayClose":70.78,"sixtyDayClose":81.12,"earningDate":1792425600000,"earningTime":"盘后","dividendPayoutRate":1.7363850728368737,"dividendFrequency":"M","dividendGrowthYears":10,"dividendGrowthRate":0.026999999999999986,"fiveYearAvgDividendRate":0.041531731300358074},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADC\",params:#limit:5,,,undefined,":[{"date":"2026-10-20","symbol":"ADC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/09","expectedEps":1.11,"defaultRemindTime":1792526400000,"name":null,"time":"盘后","dateTimestamp":1792468800000,"actualEps":null},{"date":"2026-09-30","symbol":"ADC","amount":0.267,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-30","defaultRemindTime":1790775000000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-14","payableDate":"2026-09-30","currency":"USD","dateTimestamp":1790740800000,"payDate":"2026-10-14"},{"date":"2026-08-31","symbol":"ADC","amount":0.267,"announcedDate":"2026-08-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-31","defaultRemindTime":1788183000000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-15","payableDate":"2026-08-31","currency":"USD","dateTimestamp":1788148800000,"payDate":"2026-09-15"},{"date":"2026-07-31","symbol":"ADC","amount":0.267,"announcedDate":"2026-07-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-31","defaultRemindTime":1785504600000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-14","payableDate":"2026-07-31","currency":"USD","dateTimestamp":1785470400000,"payDate":"2026-08-14"},{"date":"2026-07-30","symbol":"ADC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":1.11,"defaultRemindTime":1785441600000,"name":null,"time":"盘后","dateTimestamp":1785384000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADC\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2017-01-03","value":0.495,"currency":"USD"},{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-14","value":0.495,"currency":"USD"},{"executeDate":"2017-06-28","recordDate":"2017-06-30","paymentDate":"2017-07-14","value":0.505,"currency":"USD"},{"executeDate":"2017-09-28","recordDate":"2017-09-29","paymentDate":"2017-10-13","value":0.505,"currency":"USD"},{"executeDate":"2017-12-19","recordDate":"2017-12-20","paymentDate":"2018-01-03","value":0.52,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2381,"buy":0.381,"hold":0.381,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.381,"analysts":21,"updateTime":1784260800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADC","date":"2026-10-09","current":35.735695,"percent":0.151713,"low":31.539495,"twenty":37.338438,"median":41.108444,"eighty":43.472166,"high":50.705944,"avg":40.567126,"sd":3.64408,"marketCap":8174337844},"quantilePoints":[{"date":"2021-10-15","current":49.02563,"twenty":31.977009,"median":39.430911,"eighty":45.094688,"marketCap":4772841185},{"date":"2021-10-22","current":49.5269,"twenty":31.977009,"median":39.430911,"eighty":45.190701,"marketCap":4821641836},{"date":"2021-10-29","current":50.169373,"twenty":32.013133,"median":39.571166,"eighty":45.28245,"marketCap":4884189150},{"date":"2021-11-05","current":43.773853,"twenty":32.013133,"median":39.651928,"eighty":45.28245,"marketCap":4934976633},{"date":"2021-11-12","current":43.137928,"twenty":32.029424,"median":39.72736,"eighty":45.28245,"marketCap":4863283742},{"date":"2021-11-19","current":43.008274,"twenty":32.198132,"median":39.802558,"eighty":45.28245,"marketCap":4848666745},{"date":"2021-11-26","current":42.662528,"twenty":32.27459,"median":39.842867,"eighty":45.28245,"marketCap":4809688086},{"date":"2021-12-03","current":42.508177,"twenty":32.348817,"median":39.911012,"eighty":45.28245,"marketCap":4792286899},{"date":"2021-12-10","current":42.891493,"twenty":32.447032,"median":39.953188,"eighty":45.28245,"marketCap":4835501148},{"date":"2021-12-17","current":45.380751,"twenty":32.521786,"median":39.996581,"eighty":45.380751,"marketCap":5116135105},{"date":"2021-12-23","current":46.352906,"twenty":32.588031,"median":40.079057,"eighty":45.406143,"marketCap":5225733953},{"date":"2021-12-31","current":48.175698,"twenty":32.64443,"median":40.10618,"eighty":45.47788,"marketCap":5431231792},{"date":"2022-01-07","current":46.703962,"twenty":32.651599,"median":40.164071,"eighty":45.565296,"marketCap":5265311314},{"date":"2022-01-14","current":46.015352,"twenty":32.70478,"median":40.208708,"eighty":45.667046,"marketCap":5187678797},{"date":"2022-01-21","current":43.267663,"twenty":32.731462,"median":40.224323,"eighty":45.667046,"marketCap":4877909831},{"date":"2022-01-28","current":43.821252,"twenty":32.743358,"median":40.249944,"eighty":45.667046,"marketCap":4940320287},{"date":"2022-02-04","current":42.666817,"twenty":32.769192,"median":40.314701,"eighty":45.667046,"marketCap":4810171655},{"date":"2022-02-11","current":42.565551,"twenty":32.769192,"median":40.347561,"eighty":45.667046,"marketCap":4798755108},{"date":"2022-02-18","current":42.943612,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4841376882},{"date":"2022-02-25","current":37.784604,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4620036905},{"date":"2022-03-04","current":38.267307,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4679058463},{"date":"2022-03-11","current":37.29027,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4559593141},{"date":"2022-03-18","current":37.24956,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4554615419},{"date":"2022-03-25","current":38.110019,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4659826391},{"date":"2022-04-01","current":39.298046,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4805089927},{"date":"2022-04-08","current":39.763938,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4862056020},{"date":"2022-04-14","current":40.742313,"twenty":32.769192,"median":40.404479,"eighty":45.667046,"marketCap":4981684815},{"date":"2022-04-22","current":42.01187,"twenty":32.769192,"median":40.455317,"eighty":45.667046,"marketCap":5136917418},{"date":"2022-04-29","current":39.554287,"twenty":32.79826,"median":40.479695,"eighty":45.667046,"marketCap":4836421278},{"date":"2022-05-06","current":39.499614,"twenty":32.904642,"median":40.479695,"eighty":45.667046,"marketCap":5066773466},{"date":"2022-05-13","current":39.967203,"twenty":32.996397,"median":40.479695,"eighty":45.667046,"marketCap":5126753027},{"date":"2022-05-20","current":39.90291,"twenty":33.05702,"median":40.479695,"eighty":45.667046,"marketCap":5118505838},{"date":"2022-05-27","current":40.353768,"twenty":33.088236,"median":40.495181,"eighty":45.667046,"marketCap":5176339242},{"date":"2022-06-03","current":40.599257,"twenty":33.156377,"median":40.53176,"eighty":45.667046,"marketCap":5207829139},{"date":"2022-06-10","current":41.119461,"twenty":33.227354,"median":40.613635,"eighty":45.667046,"marketCap":5274557730},{"date":"2022-06-17","current":40.213488,"twenty":33.270165,"median":40.613635,"eighty":45.667046,"marketCap":5158345016},{"date":"2022-06-24","current":43.32302,"twenty":33.260026,"median":40.659236,"eighty":45.668114,"marketCap":5557217043},{"date":"2022-07-01","current":42.978166,"twenty":33.330747,"median":40.684242,"eighty":45.668114,"marketCap":5512981235},{"date":"2022-07-08","current":42.872956,"twenty":33.466784,"median":40.715658,"eighty":45.668114,"marketCap":5499485565},{"date":"2022-07-15","current":43.708789,"twenty":33.59929,"median":40.742313,"eighty":45.668114,"marketCap":5606701167},{"date":"2022-07-22","current":44.556311,"twenty":33.59929,"median":40.778643,"eighty":45.668114,"marketCap":5715416287},{"date":"2022-07-29","current":46.520226,"twenty":33.675236,"median":40.820493,"eighty":45.678143,"marketCap":5967335462},{"date":"2022-08-05","current":43.100932,"twenty":33.675236,"median":40.862996,"eighty":45.68777,"marketCap":6116022220},{"date":"2022-08-12","current":44.318758,"twenty":33.675236,"median":40.912721,"eighty":45.68777,"marketCap":6288831702},{"date":"2022-08-19","current":44.509569,"twenty":33.675236,"median":40.969109,"eighty":45.68777,"marketCap":6315907842},{"date":"2022-08-26","current":43.241234,"twenty":33.675236,"median":41.010201,"eighty":45.68777,"marketCap":6135931147},{"date":"2022-09-02","current":41.585665,"twenty":33.675236,"median":41.060268,"eighty":45.68777,"marketCap":5901005814},{"date":"2022-09-09","current":41.956063,"twenty":33.675236,"median":41.092655,"eighty":45.68777,"marketCap":5953565380},{"date":"2022-09-16","current":40.805583,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5790312183},{"date":"2022-09-23","current":39.935707,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5666876838},{"date":"2022-09-30","current":37.927001,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5381841428},{"date":"2022-10-07","current":36.428553,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5169211706},{"date":"2022-10-14","current":35.631626,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5056127734},{"date":"2022-10-21","current":36.636203,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5198677248},{"date":"2022-10-28","current":38.359137,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5443161610},{"date":"2022-11-04","current":41.724424,"twenty":33.675236,"median":41.119461,"eighty":45.68777,"marketCap":6035896875},{"date":"2022-11-11","current":42.347632,"twenty":33.675236,"median":41.160749,"eighty":45.68777,"marketCap":6126050848},{"date":"2022-11-18","current":42.756995,"twenty":33.675236,"median":41.197005,"eighty":45.68777,"marketCap":6185269635},{"date":"2022-11-25","current":43.056379,"twenty":33.675236,"median":41.218321,"eighty":45.68777,"marketCap":6228578896},{"date":"2022-12-02","current":43.196907,"twenty":33.675236,"median":41.257018,"eighty":45.68777,"marketCap":6248907733},{"date":"2022-12-09","current":43.795676,"twenty":33.675236,"median":41.35326,"eighty":45.68777,"marketCap":6335526256},{"date":"2022-12-16","current":43.172467,"twenty":33.675236,"median":41.423201,"eighty":45.68777,"marketCap":6245372283},{"date":"2022-12-23","current":43.685698,"twenty":33.675236,"median":41.463369,"eighty":45.68777,"marketCap":6319616732},{"date":"2022-12-30","current":43.337434,"twenty":33.675236,"median":41.483593,"eighty":45.68777,"marketCap":6269236570},{"date":"2023-01-06","current":43.245786,"twenty":34.167053,"median":41.539601,"eighty":45.68777,"marketCap":6255978633},{"date":"2023-01-13","current":45.714181,"twenty":34.992765,"median":41.587683,"eighty":45.704396,"marketCap":6613059075},{"date":"2023-01-20","current":45.402576,"twenty":35.880519,"median":41.605991,"eighty":45.714503,"marketCap":6567982088},{"date":"2023-01-27","current":45.378137,"twenty":36.169649,"median":41.646285,"eighty":45.714503,"marketCap":6564446638},{"date":"2023-02-03","current":45.255939,"twenty":36.592515,"median":41.674422,"eighty":45.714503,"marketCap":6546769389},{"date":"2023-02-10","current":44.406665,"twenty":36.713651,"median":41.711398,"eighty":45.714503,"marketCap":6423912504},{"date":"2023-02-17","current":44.157808,"twenty":36.89773,"median":41.739833,"eighty":45.714503,"marketCap":6731283715},{"date":"2023-02-24","current":42.410386,"twenty":36.963658,"median":41.754028,"eighty":45.714503,"marketCap":6464912060},{"date":"2023-03-03","current":41.690165,"twenty":37.214665,"median":41.783816,"eighty":45.714503,"marketCap":6355123742},{"date":"2023-03-10","current":39.423241,"twenty":37.286636,"median":41.783816,"eighty":45.714503,"marketCap":6009560514},{"date":"2023-03-17","current":40.355986,"twenty":37.342014,"median":41.783816,"eighty":45.714503,"marketCap":6151745384},{"date":"2023-03-24","current":39.606247,"twenty":37.466803,"median":41.783816,"eighty":45.714503,"marketCap":6037457546},{"date":"2023-03-31","current":40.621801,"twenty":37.536428,"median":41.78137,"eighty":45.714342,"marketCap":6192265465},{"date":"2023-04-06","current":39.692254,"twenty":37.577737,"median":41.783816,"eighty":45.714503,"marketCap":6050568092},{"date":"2023-04-14","current":39.289647,"twenty":37.687654,"median":41.784219,"eighty":45.714663,"marketCap":5989195981},{"date":"2023-04-21","current":39.792905,"twenty":37.872566,"median":41.784621,"eighty":45.714824,"marketCap":6065911119},{"date":"2023-04-28","current":40.118543,"twenty":37.943837,"median":41.797292,"eighty":45.714985,"marketCap":6115550327},{"date":"2023-05-05","current":39.964605,"twenty":38.110019,"median":41.797292,"eighty":45.714985,"marketCap":6092084520},{"date":"2023-05-12","current":39.104119,"twenty":38.249787,"median":41.797292,"eighty":45.714985,"marketCap":6176026400},{"date":"2023-05-19","current":38.898029,"twenty":38.342909,"median":41.797292,"eighty":45.714985,"marketCap":6143476946},{"date":"2023-05-26","current":37.796919,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5969569863},{"date":"2023-06-02","current":37.832249,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5975149770},{"date":"2023-06-09","current":38.668386,"twenty":38.476762,"median":41.797292,"eighty":45.714985,"marketCap":6107207554},{"date":"2023-06-16","current":38.786152,"twenty":38.533217,"median":41.797292,"eighty":45.714985,"marketCap":6125807242},{"date":"2023-06-23","current":38.509402,"twenty":38.553397,"median":41.809962,"eighty":45.718688,"marketCap":6082097976},{"date":"2023-06-30","current":38.55062,"twenty":38.5799,"median":41.81327,"eighty":45.72239,"marketCap":6088607866},{"date":"2023-07-07","current":38.662498,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6106277570},{"date":"2023-07-14","current":38.603615,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6096977726},{"date":"2023-07-21","current":39.357316,"twenty":38.659115,"median":41.81327,"eighty":45.72239,"marketCap":6216015729},{"date":"2023-07-28","current":39.404422,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6223455604},{"date":"2023-08-04","current":38.053978,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6196443469},{"date":"2023-08-11","current":37.511193,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6108060089},{"date":"2023-08-18","current":36.166029,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5889023018},{"date":"2023-08-25","current":36.531819,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5948585730},{"date":"2023-09-01","current":36.472821,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5938978841},{"date":"2023-09-08","current":35.75304,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5821774794},{"date":"2023-09-15","current":35.446248,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5771818971},{"date":"2023-09-22","current":33.711695,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5489376431},{"date":"2023-09-29","current":32.567126,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5303002783},{"date":"2023-10-06","current":32.649724,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5316452427},{"date":"2023-10-13","current":31.806046,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5179073913},{"date":"2023-10-20","current":32.41963,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5278985560},{"date":"2023-10-27","current":33.181375,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5472604212},{"date":"2023-11-03","current":35.377246,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5834769220},{"date":"2023-11-10","current":34.598655,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5706356142},{"date":"2023-11-17","current":35.425908,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5842795038},{"date":"2023-11-24","current":35.170433,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5800659496},{"date":"2023-12-01","current":36.015934,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5940108073},{"date":"2023-12-08","current":36.873602,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6081563104},{"date":"2023-12-15","current":37.7556,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6227031044},{"date":"2023-12-22","current":37.968496,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6262143995},{"date":"2023-12-29","current":38.607184,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":6367482847},{"date":"2024-01-05","current":38.296964,"twenty":38.756995,"median":41.871582,"eighty":45.73451,"marketCap":6316318262},{"date":"2024-01-12","current":38.090151,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":6282208538},{"date":"2024-01-19","current":36.989174,"twenty":38.764196,"median":41.872103,"eighty":45.735522,"marketCap":6100624420},{"date":"2024-01-26","current":36.295741,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":5986256523},{"date":"2024-02-02","current":37.232484,"twenty":38.697827,"median":41.871582,"eighty":45.73451,"marketCap":6140753507},{"date":"2024-02-09","current":35.261674,"twenty":38.661168,"median":41.871582,"eighty":45.73451,"marketCap":5815707904},{"date":"2024-02-16","current":33.847315,"twenty":38.629468,"median":41.871582,"eighty":45.73451,"marketCap":5752655855},{"date":"2024-02-23","current":33.670228,"twenty":38.597685,"median":41.871582,"eighty":45.73451,"marketCap":5722558249},{"date":"2024-03-01","current":32.436519,"twenty":38.556509,"median":41.871061,"eighty":45.733498,"marketCap":5512878257},{"date":"2024-03-08","current":33.758772,"twenty":38.535146,"median":41.871061,"eighty":45.733498,"marketCap":5737607052},{"date":"2024-03-15","current":32.6018,"twenty":38.489062,"median":41.871061,"eighty":45.733498,"marketCap":5540969356},{"date":"2024-03-22","current":33.262927,"twenty":38.456408,"median":41.871061,"eighty":45.733498,"marketCap":5653333754},{"date":"2024-03-28","current":33.457723,"twenty":38.385748,"median":41.784621,"eighty":45.733498,"marketCap":5686441121},{"date":"2024-04-05","current":33.192092,"twenty":38.338315,"median":41.766476,"eighty":45.73451,"marketCap":5641294711},{"date":"2024-04-12","current":33.499043,"twenty":38.271415,"median":41.746116,"eighty":45.73451,"marketCap":5693463896},{"date":"2024-04-19","current":32.99201,"twenty":38.226469,"median":41.73308,"eighty":45.73451,"marketCap":5607289064},{"date":"2024-04-26","current":33.647761,"twenty":38.150217,"median":41.720309,"eighty":45.733498,"marketCap":5827926731},{"date":"2024-05-03","current":33.618779,"twenty":38.090151,"median":41.711398,"eighty":45.733498,"marketCap":5822906984},{"date":"2024-05-10","current":34.482434,"twenty":38.029323,"median":41.69585,"eighty":45.733498,"marketCap":5972495456},{"date":"2024-05-17","current":34.986715,"twenty":37.950247,"median":41.66791,"eighty":45.733498,"marketCap":6059839061},{"date":"2024-05-24","current":34.198413,"twenty":37.871294,"median":41.619337,"eighty":45.733498,"marketCap":5923301932},{"date":"2024-05-31","current":34.928752,"twenty":37.820473,"median":41.602226,"eighty":45.733498,"marketCap":6049799566},{"date":"2024-06-07","current":35.908334,"twenty":37.7418,"median":41.585665,"eighty":45.733498,"marketCap":6219467028},{"date":"2024-06-14","current":35.311311,"twenty":37.642264,"median":41.478607,"eighty":45.73451,"marketCap":6116060232},{"date":"2024-06-21","current":35.485201,"twenty":37.563829,"median":41.447441,"eighty":45.735522,"marketCap":6146178716},{"date":"2024-06-28","current":35.734443,"twenty":37.537078,"median":41.447441,"eighty":45.738558,"marketCap":6189348544},{"date":"2024-07-05","current":35.879352,"twenty":37.482188,"median":41.447441,"eighty":45.738558,"marketCap":6214447281},{"date":"2024-07-12","current":36.957471,"twenty":37.418215,"median":41.439295,"eighty":45.738558,"marketCap":6401181884},{"date":"2024-07-15","current":37.189325,"twenty":37.412399,"median":41.439295,"eighty":45.738558,"marketCap":6441339863},{"date":"2024-08-02","current":37.993919,"twenty":37.339153,"median":41.40142,"eighty":45.707657,"marketCap":7107142493},{"date":"2024-08-09","current":38.417922,"twenty":37.339153,"median":41.351038,"eighty":45.669183,"marketCap":7186456557},{"date":"2024-08-16","current":38.455492,"twenty":37.339153,"median":41.248609,"eighty":45.587895,"marketCap":7193484385},{"date":"2024-08-23","current":38.879496,"twenty":37.339153,"median":41.197005,"eighty":45.51208,"marketCap":7272798449},{"date":"2024-08-30","current":39.104915,"twenty":37.339153,"median":41.152223,"eighty":45.432939,"marketCap":7314965420},{"date":"2024-09-06","current":40.19981,"twenty":37.339153,"median":41.109476,"eighty":45.406991,"marketCap":7519776420},{"date":"2024-09-13","current":40.725789,"twenty":37.339153,"median":41.060268,"eighty":45.379705,"marketCap":7618166018},{"date":"2024-09-20","current":39.786541,"twenty":37.339153,"median":41.020981,"eighty":45.296882,"marketCap":7442470307},{"date":"2024-09-27","current":39.931453,"twenty":37.339153,"median":40.992653,"eighty":45.271719,"marketCap":7469577645},{"date":"2024-10-04","current":40.355457,"twenty":37.339153,"median":40.937316,"eighty":45.211095,"marketCap":7548891709},{"date":"2024-10-11","current":39.3196,"twenty":37.339153,"median":40.894276,"eighty":45.159517,"marketCap":7355124439},{"date":"2024-10-18","current":40.731156,"twenty":37.339153,"median":40.838938,"eighty":45.089028,"marketCap":7619169993},{"date":"2024-10-25","current":42.532506,"twenty":37.339153,"median":40.820493,"eighty":45.046981,"marketCap":8077475775},{"date":"2024-10-31","current":40.816625,"twenty":37.339153,"median":40.816625,"eighty":44.988744,"marketCap":7751607762},{"date":"2024-11-08","current":40.076878,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7611120201},{"date":"2024-11-15","current":41.115788,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7808422584},{"date":"2024-11-22","current":41.948003,"twenty":37.338438,"median":40.773001,"eighty":44.914929,"marketCap":7966471090},{"date":"2024-11-29","current":41.773945,"twenty":37.338438,"median":40.773001,"eighty":44.914324,"marketCap":7933415193},{"date":"2024-12-06","current":40.849261,"twenty":37.338438,"median":40.770318,"eighty":44.892115,"marketCap":7757805742},{"date":"2024-12-13","current":40.055121,"twenty":37.338438,"median":40.736734,"eighty":44.892115,"marketCap":7606988214},{"date":"2024-12-20","current":37.770608,"twenty":37.338438,"median":40.680888,"eighty":44.892115,"marketCap":7173129570},{"date":"2024-12-27","current":38.515795,"twenty":37.338438,"median":40.640959,"eighty":44.892115,"marketCap":7314650128},{"date":"2025-01-03","current":37.933788,"twenty":37.338438,"median":40.614232,"eighty":44.892115,"marketCap":7204119473},{"date":"2025-01-10","current":37.906591,"twenty":37.337724,"median":40.580698,"eighty":44.89414,"marketCap":7198954490},{"date":"2025-01-17","current":39.244663,"twenty":37.333873,"median":40.538993,"eighty":44.89414,"marketCap":7453071695},{"date":"2025-01-24","current":38.87479,"twenty":37.333873,"median":40.501145,"eighty":44.89414,"marketCap":7382827915},{"date":"2025-01-31","current":39.761398,"twenty":37.333873,"median":40.465332,"eighty":44.84311,"marketCap":7551206388},{"date":"2025-02-07","current":39.74508,"twenty":37.333873,"median":40.424995,"eighty":44.718497,"marketCap":7548107398},{"date":"2025-02-14","current":40.634976,"twenty":37.333873,"median":40.403761,"eighty":44.67404,"marketCap":7688015540},{"date":"2025-02-21","current":40.363435,"twenty":37.333873,"median":40.374953,"eighty":44.653159,"marketCap":7636640801},{"date":"2025-02-28","current":41.687197,"twenty":37.333873,"median":40.374953,"eighty":44.559412,"marketCap":7887092651},{"date":"2025-03-07","current":42.394335,"twenty":37.33306,"median":40.37194,"eighty":44.562299,"marketCap":8020881032},{"date":"2025-03-14","current":42.767704,"twenty":37.33306,"median":40.383179,"eighty":44.562299,"marketCap":8091521298},{"date":"2025-03-21","current":43.141073,"twenty":37.417052,"median":40.40791,"eighty":44.562299,"marketCap":8162161563},{"date":"2025-03-28","current":42.993988,"twenty":37.479862,"median":40.452151,"eighty":44.562299,"marketCap":8134333580},{"date":"2025-04-04","current":43.440899,"twenty":37.536428,"median":40.487288,"eighty":44.562299,"marketCap":8218887836},{"date":"2025-04-11","current":41.268572,"twenty":37.537078,"median":40.501145,"eighty":44.559412,"marketCap":7807889929},{"date":"2025-04-17","current":44.145605,"twenty":37.540692,"median":40.519212,"eighty":44.559412,"marketCap":8352216066},{"date":"2025-04-25","current":43.782817,"twenty":37.571542,"median":40.572736,"eighty":44.653759,"marketCap":8377141546},{"date":"2025-05-02","current":45.953462,"twenty":37.571542,"median":40.583839,"eighty":44.677947,"marketCap":8792459672},{"date":"2025-05-09","current":43.031008,"twenty":37.571542,"median":40.598117,"eighty":44.677947,"marketCap":8233294969},{"date":"2025-05-16","current":42.422675,"twenty":37.571542,"median":40.624906,"eighty":44.677947,"marketCap":8116900028},{"date":"2025-05-23","current":42.755537,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8180587826},{"date":"2025-05-30","current":42.698147,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8169607171},{"date":"2025-06-06","current":42.411197,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8114703897},{"date":"2025-06-13","current":42.927706,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8213529790},{"date":"2025-06-20","current":43.220395,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8269531129},{"date":"2025-06-27","current":41.894687,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8015878004},{"date":"2025-07-03","current":41.30357,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7902777259},{"date":"2025-07-11","current":40.735409,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7794068777},{"date":"2025-07-18","current":41.234702,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7889600473},{"date":"2025-07-25","current":42.319373,"twenty":37.604201,"median":40.725789,"eighty":44.606841,"marketCap":8097134849},{"date":"2025-08-01","current":42.372392,"twenty":37.604201,"median":40.742491,"eighty":44.606841,"marketCap":7873129491},{"date":"2025-08-08","current":43.918584,"twenty":37.604201,"median":40.752858,"eighty":44.633348,"marketCap":8160424292},{"date":"2025-08-15","current":42.901923,"twenty":37.604201,"median":40.790693,"eighty":44.633348,"marketCap":7971520467},{"date":"2025-08-22","current":44.019656,"twenty":37.604201,"median":40.820493,"eighty":44.633348,"marketCap":8179204204},{"date":"2025-08-29","current":43.199192,"twenty":37.604201,"median":40.894276,"eighty":44.633348,"marketCap":8026755504},{"date":"2025-09-05","current":42.806797,"twenty":37.595885,"median":40.935905,"eighty":44.639951,"marketCap":7953845256},{"date":"2025-09-12","current":43.841294,"twenty":37.604201,"median":40.969944,"eighty":44.633348,"marketCap":8146063183},{"date":"2025-09-19","current":42.527363,"twenty":37.604201,"median":41.008406,"eighty":44.633348,"marketCap":7901924321},{"date":"2025-09-26","current":41.962551,"twenty":37.639342,"median":41.035693,"eighty":44.633348,"marketCap":7796977752},{"date":"2025-10-03","current":42.027951,"twenty":37.639342,"median":41.102705,"eighty":44.633348,"marketCap":7809129460},{"date":"2025-10-10","current":41.974442,"twenty":37.639342,"median":41.115788,"eighty":44.633348,"marketCap":7799187153},{"date":"2025-10-17","current":44.322871,"twenty":37.639342,"median":41.17126,"eighty":44.633348,"marketCap":8235543942},{"date":"2025-10-24","current":44.544295,"twenty":37.639342,"median":41.220151,"eighty":44.656944,"marketCap":8621592904},{"date":"2025-10-31","current":43.1986,"twenty":37.639342,"median":41.2516,"eighty":44.656944,"marketCap":8361132219},{"date":"2025-11-07","current":42.991114,"twenty":37.639342,"median":41.30357,"eighty":44.656944,"marketCap":8320973082},{"date":"2025-11-14","current":43.690638,"twenty":37.639342,"median":41.35326,"eighty":44.656944,"marketCap":8456366743},{"date":"2025-11-21","current":43.68471,"twenty":37.639342,"median":41.452784,"eighty":44.656944,"marketCap":8455219339},{"date":"2025-11-28","current":44.591721,"twenty":37.639342,"median":41.521652,"eighty":44.656944,"marketCap":8630772135},{"date":"2025-12-05","current":44.093754,"twenty":37.639342,"median":41.583569,"eighty":44.656944,"marketCap":8534390208},{"date":"2025-12-12","current":42.244164,"twenty":37.639342,"median":41.619337,"eighty":44.656944,"marketCap":8176400191},{"date":"2025-12-19","current":42.902191,"twenty":37.639342,"median":41.692355,"eighty":44.656944,"marketCap":8303762024},{"date":"2025-12-26","current":42.919976,"twenty":37.639342,"median":41.746748,"eighty":44.656944,"marketCap":8307204236},{"date":"2026-01-02","current":42.700633,"twenty":37.639342,"median":41.754028,"eighty":44.656944,"marketCap":8264750291},{"date":"2026-01-09","current":41.977396,"twenty":37.639342,"median":41.778924,"eighty":44.654358,"marketCap":8124767015},{"date":"2026-01-16","current":42.688777,"twenty":37.639342,"median":41.778924,"eighty":44.603089,"marketCap":8262455483},{"date":"2026-01-23","current":42.700633,"twenty":37.639342,"median":41.778924,"eighty":44.565186,"marketCap":8264750291},{"date":"2026-01-30","current":42.659136,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":8256718464},{"date":"2026-02-06","current":45.131184,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":8735185890},{"date":"2026-02-13","current":44.908403,"twenty":37.639342,"median":41.778924,"eighty":44.506847,"marketCap":9176987197},{"date":"2026-02-20","current":45.230936,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":9242896611},{"date":"2026-02-27","current":46.784962,"twenty":37.639342,"median":41.778924,"eighty":44.52786,"marketCap":9560460154},{"date":"2026-03-06","current":47.517993,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9710254277},{"date":"2026-03-13","current":46.714591,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9546079918},{"date":"2026-03-20","current":46.13403,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9427442972},{"date":"2026-03-27","current":43.629997,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":8915746245},{"date":"2026-04-02","current":44.474448,"twenty":37.639342,"median":41.778924,"eighty":44.463484,"marketCap":9088309076},{"date":"2026-04-10","current":45.752298,"twenty":37.639342,"median":41.778924,"eighty":44.447073,"marketCap":9349436265},{"date":"2026-04-17","current":46.315619,"twenty":37.639342,"median":41.778924,"eighty":44.447073,"marketCap":9464550524},{"date":"2026-04-24","current":42.221567,"twenty":37.639342,"median":41.778924,"eighty":44.388105,"marketCap":9263580602},{"date":"2026-05-01","current":42.145034,"twenty":37.639342,"median":41.773945,"eighty":44.310918,"marketCap":9246788997},{"date":"2026-05-08","current":41.718719,"twenty":37.639342,"median":41.749425,"eighty":44.205061,"marketCap":9153253847},{"date":"2026-05-15","current":41.144834,"twenty":37.639342,"median":41.735116,"eighty":44.170042,"marketCap":9027341145},{"date":"2026-05-22","current":41.363457,"twenty":37.639342,"median":41.708673,"eighty":44.159332,"marketCap":9075307889},{"date":"2026-05-29","current":40.745847,"twenty":37.635958,"median":41.645687,"eighty":44.142784,"marketCap":8939801838},{"date":"2026-06-05","current":39.477834,"twenty":37.639342,"median":41.613421,"eighty":44.076208,"marketCap":8661594725},{"date":"2026-06-12","current":40.871555,"twenty":37.639342,"median":41.561825,"eighty":44.020119,"marketCap":8967382716},{"date":"2026-06-18","current":40.341395,"twenty":37.639342,"median":41.522683,"eighty":43.960147,"marketCap":8851063362},{"date":"2026-06-26","current":41.527424,"twenty":37.635958,"median":41.458055,"eighty":43.866662,"marketCap":9111282946},{"date":"2026-07-02","current":41.691391,"twenty":37.635958,"median":41.455214,"eighty":43.838916,"marketCap":9147258004},{"date":"2026-07-10","current":42.549486,"twenty":37.635958,"median":41.455214,"eighty":43.812381,"marketCap":9335527473},{"date":"2026-07-17","current":44.134502,"twenty":37.635958,"median":41.455214,"eighty":43.800235,"marketCap":9683286364},{"date":"2026-07-24","current":43.620739,"twenty":37.635958,"median":41.455214,"eighty":43.790532,"marketCap":9570564516},{"date":"2026-07-31","current":43.306779,"twenty":37.632574,"median":41.452784,"eighty":43.772108,"marketCap":9737919027},{"date":"2026-08-07","current":42.169016,"twenty":37.632574,"median":41.452784,"eighty":43.730794,"marketCap":9482082868},{"date":"2026-08-14","current":41.48415,"twenty":37.632574,"median":41.412647,"eighty":43.686617,"marketCap":9328084404},{"date":"2026-08-21","current":41.119624,"twenty":37.632574,"median":41.35326,"eighty":43.679447,"marketCap":9246117479},{"date":"2026-08-28","current":40.429234,"twenty":37.632574,"median":41.30357,"eighty":43.643751,"marketCap":9090877092},{"date":"2026-09-04","current":40.169647,"twenty":37.632574,"median":41.279794,"eighty":43.619299,"marketCap":9032506706},{"date":"2026-09-11","current":39.48478,"twenty":37.632574,"median":41.2516,"eighty":43.588862,"marketCap":8878508241},{"date":"2026-09-18","current":37.645582,"twenty":37.632468,"median":41.211986,"eighty":43.520728,"marketCap":8464947849},{"date":"2026-09-25","current":37.104316,"twenty":37.487989,"median":41.17126,"eighty":43.502078,"marketCap":8343239385},{"date":"2026-10-02","current":35.916845,"twenty":37.413562,"median":41.155429,"eighty":43.482983,"marketCap":8076225919},{"date":"2026-10-09","current":36.353172,"twenty":37.338438,"median":41.108444,"eighty":43.472166,"marketCap":8174337844}],"updateTime":1791868858302},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADC\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660486161","title":"百利天恒：双抗ADC药物非小细胞肺癌III期临床达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2660486161","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660486161?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 17:34","pubTimestamp":1786959283,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["III","NETL","ADC","BK4080","BK4231","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659147909","title":"博安生物(06955)：BA1302 (CD228 ADC)完成中国Ia期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2659147909","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659147909?lang=zh_cn&edition=fundamental","pubTime":"2026-08-14 22:22","pubTimestamp":1786717377,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博安生物 发布公告，公司自主研发的靶向CD228的创新抗体偶联药物BA1302已完成中国I期临床研究单药剂量递增阶段(Ia期)。研究结果显示，BA1302在经多线治疗后疾病仍进展的多种晚期实体瘤患者中展现出良好的抗肿瘤活性，整体安全耐受性良好。据公司所知，BA1302是目前全球唯一处于临床阶段的靶向CD228 ADC。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480359.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06955","BK4080","NETL","ADC","BK4231","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659618195","title":"艾力斯医药获得ArriVent潜在全球首创ADC权益；京东健康上半年累计首发65款新药 | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2659618195","media":"每日经济新闻","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659618195?lang=zh_cn&edition=fundamental","pubTime":"2026-08-14 07:01","pubTimestamp":1786662085,"startTime":"0","endTime":"0","summary":"丨2026年8月14日星期五丨NO.1艾力斯医药获得ArriVent潜在全球首创ADC权益8月13日，艾力斯宣布与ArriVentBioPharma,Inc.(ArriVent)签署战略合作协议，公司获得在中国研究、开发、生产、注册以及商业化抗体偶联药物（ADC）AST12608/ARR-002的独占许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608143840884969.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608143840884969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4080","LU0051755006.USD","BK1615","BK1515","NETL","BK1574","SGXZ86797644.SGD","BK1591","86618","BK1142","09939","BK4231","ADC","LU0456827905.SGD","BK0239","688578","BK1583","BK1589","BK1571","BK1161","BK1247","SGXZ62798434.SGD","06618","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659860121","title":"第一三共/阿斯利康(AZN.US)重磅ADC药物“德曲妥珠单抗”又一项新适应症在中国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2659860121","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659860121?lang=zh_cn&edition=fundamental","pubTime":"2026-08-13 07:21","pubTimestamp":1786576889,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月12日，第一三共宣布，其与阿斯利康合作开发的重磅ADC药物“德曲妥珠单抗”一项新适应症获批上市，适应症为联合帕妥珠单抗用于不可切除或转移性HER2阳性成人乳腺癌患者的一线治疗。德曲妥珠单抗(DS-8201，商品名：优赫得®/Enhertu)是一款靶向HER2的ADC药物，由第一三共开发，并与阿斯利康在全球范围内共同开发和商业化。该药由HER2靶向抗体、可裂解四肽连接子和拓扑异构酶I抑制剂DXd(依喜替康衍生物)组成，DAR约为8。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2456880835.USD","LU0889565916.HKD","LU0128525929.USD","LU2468319806.SGD","LU0310800379.SGD","IPOS","LU0320765992.SGD","LU0708994859.HKD","AZNH","BK4231","LU2237443382.USD","BK4585","LU1829250122.USD","NETL","LU0432979614.USD","LU2237443549.SGD","LU0289739699.SGD","LU2237443895.HKD","LU2236285917.USD","LU2089984988.USD","LU0029864427.USD","LU0058720904.USD","ADC","LU2237443622.USD","LU2237443978.SGD","LU0109394709.USD","LU2417539215.USD","BK4007","BK4568","BK4080","LU2462157665.USD","LU2237443465.HKD","BK4588","IE00B3T34201.USD","AZN","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658976102","title":"优赫得联合帕妥珠单抗在华获批HER2阳性转移性乳腺癌一线治疗，成为十余年来该领域首个获批的创新ADC方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2658976102","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658976102?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 17:15","pubTimestamp":1786526100,"startTime":"0","endTime":"0","summary":"德曲妥珠单抗联合帕妥珠单抗组的PFS获益在各个预设亚组中均保持一致。在DESTINY-Breast09研究中，德曲妥珠单抗联合帕妥珠单抗治疗的中位无进展生存期超过三年，有望成为这一领域新的标准治疗，期待此治疗方案能使更多中国患者受益。此次获批标志着这一创新治疗方案进入了HER2阳性转移性乳腺癌更前线治疗阶段。此次获批标志着德曲妥珠单抗在中国迎来第八项适应症，其中五项为乳腺癌治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5024779_ZH24779_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5024779_ZH24779_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["AZN","BK4231","LU2237443622.USD","LU2089984988.USD","LU1829250122.USD","LU0320765992.SGD","LU2462157665.USD","LU2237443382.USD","LU2468319806.SGD","BK4588","LU0058720904.USD","LU0289739699.SGD","BK4080","LU2237443465.HKD","LU2237443549.SGD","LU1267930573.SGD","ADC","AZNH","LU0029864427.USD","BK4585","LU0432979614.USD","LU2237443895.HKD","LU0109394709.USD","LU0889565916.HKD","LU2236285917.USD","LU2456880835.USD","IE00B3T34201.USD","LU2237443978.SGD","LU0708994859.HKD","NETL","BK4568","BK4007","LU0128525929.USD","LU0310800379.SGD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658921431","title":"【券商聚焦】招商证券首予映恩生物（09606）强烈推荐评级 指ADC管线差异化优势显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2658921431","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658921431?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 14:39","pubTimestamp":1786516786,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招商证券发布研报指，映恩生物 凭借四大自主知识产权ADC技术平台，构建了覆盖肿瘤与自免疾病、从1.0到3.0全梯度的差异化管线。DB-1303针对二线及以上HER2阳性乳腺癌的III期研究已达PFS主要终点，中国BLA于2026年4月获NMPA受理；其子宫内膜癌适应症获中美突破性疗法认定，为全球少数覆盖全HER2表达水平的HER2 ADC。首次覆盖，给予“强烈推荐”投资评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988027","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","ADC","09606","06099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657622723","title":"ADC的矿源耗竭了吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2657622723","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657622723?lang=zh_cn&edition=fundamental","pubTime":"2026-08-08 11:39","pubTimestamp":1786160396,"startTime":"0","endTime":"0","summary":"于是我们听见，行业里开始流行一句半开玩笑的问话：ADC的矿源耗竭了吗？01 三代挖矿者同挖一座山ADC的矿，指的是可成药抗原：抗体识别细胞表面靶点，偶联毒素定向爆破。但到2026年，矿脉分布已经畸形：HER2：全球临床试验318项，中国企业在该靶点ADC在研数量占全球63.6%，2026年ASCO摘要池里HER2相关48个分子、104项研究，Enhertu一家占了21条。02 开采成本翻了几倍矿源耗竭的体感，来自五重挤压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1785379137813045498","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["NETL","ADC","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657641539","title":"百济神州：公司拟披露CEA ADC在非小细胞肺癌中的早期数据，覆盖鳞癌和非鳞癌患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2657641539","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657641539?lang=zh_cn&edition=fundamental","pubTime":"2026-08-07 21:24","pubTimestamp":1786109040,"startTime":"0","endTime":"0","summary":"百济神州在接受调研时表示，公司拟披露CEA ADC在非小细胞肺癌中的早期数据，覆盖鳞癌和非鳞癌患者。具体的CEA表达阈值、PD-L1表达分层及对应疗效尚未对外披露，后续数据将提供更多信息。公司不会将该产品局限于后线，正在加快向更前线及与PD-1等方案联合推进。对于CEA与KRAS共突变等细分人群，也会根据表达重叠度和早期信号开展探索。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-07/doc-inimpfyi4628080.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-07/doc-inimpfyi4628080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4231","LU1770034418.SGD","BK1583","BK4526","LU2328871848.SGD","06160","LU1303224171.USD","KURE","LU1251922891.USD","BK0239","BK1161","BK4588","LU1719994722.HKD","ONC","NETL","BK1500","ADC","LU1969619763.USD","BK4139","BK1588","LU0588546209.SGD","BK4080","688235","LU0307460666.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657259635","title":"再鼎医药2026 Q2产品环比收入增长11%，DLL3 ADC最快明年提交美国上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2657259635","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657259635?lang=zh_cn&edition=fundamental","pubTime":"2026-08-06 19:46","pubTimestamp":1786016812,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4080","ADC","BK4531","BK4139","ZLAB","IPOS","BK4526","BK4548","NETL","BK4588","BK4231","LU2488822045.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657505243","title":"港股异动 | 科伦博泰生物(06990)午前涨超4% 新型双载荷ADC药物SKB565新药临床试验申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2657505243","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657505243?lang=zh_cn&edition=fundamental","pubTime":"2026-08-06 11:16","pubTimestamp":1785986197,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科伦博泰生物(06990)午前涨超4%，截至发稿，涨3.8%，报510.5港元，成交额9592.4万港元。消息面上，科伦博泰生物近日发布公告，公司收到国家药品监督管理局药品审评中心的临床试验通知书，同意其新型双载荷ADC药物SKB565的新药临床试验申请，用于治疗晚期实体瘤。这是公司首个进入临床阶段的“双载荷”抗体偶联药物，SKB565的获批标志着公司在“ADC+IO”一体化开发策略上迈出关键一步。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476639.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","BMED","MDTX","ADC","IBBQ","BK1161","KCAI","PSYK","IBBJ","VXUS","06990","NETL","BK4588","BK4231","LU0196878994.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657516276","title":"22亿美元ADC出海改写康宁杰瑞","url":"https://stock-news.laohu8.com/highlight/detail?id=2657516276","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657516276?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 15:09","pubTimestamp":1785913740,"startTime":"0","endTime":"0","summary":"站在行业发展的角度看，双抗ADC，正在成为国产创新药出海的全新增长极。8月4日，康宁杰瑞生物制药发布重磅公告，旗下全球首创TROP2/HER3双特异性抗体偶联药物（ADC）JSKN016达成海外独家授权合作，与美国AI驱动肿瘤新药研发企业PathosAI签约，交易总潜在金额最高达22.18亿美元（约合142.2亿元），创下国产双抗ADC出海的新里程碑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053832538126.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053832538126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2272731600.USD","BK4148","LU0348723411.USD","BK4585","IE00BFMHRM44.USD","BK4588","LU2272731865.HKD","LU1548497426.USD","BK4231","LU1992135399.USD","LU2322448957.HKD","LU1720051108.HKD","LU2473716301.USD","LU2265009873.SGD","LU2272731782.SGD","LU1804176565.USD","LU1720051017.SGD","GLWG","LU1992135472.HKD","ADC","LU2322448791.USD","CNAV","BK4080","GLW","LU2543165471.USD","RULE","LU2357305700.SGD","BK4512","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656538672","title":"港股异动 | 百奥赛图-B(02315)涨超10% 双抗ADC推进海外开发 临床前CRO与模型鼠景气度上行","url":"https://stock-news.laohu8.com/highlight/detail?id=2656538672","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656538672?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 15:00","pubTimestamp":1785826839,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B涨超10%，截至发稿，涨10.39%，报57.9港元，成交额8028.46万港元。消息面上，百奥赛图上月宣布与Whitehawk Therapeutics, Inc.签署一项全球战略合作协议，涵盖多个双特异性抗体偶联药物研发项目，双方将共同推进多元化的新一代治疗产品管线。据悉，从双方正式启动合作到完成协议签署，历时仅仅约四个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475697.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4080","BK4585","KCAI","BK0216","VXUS","NETL","02315","ADC","688796","BK1161","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656963586","title":"康宁杰瑞制药-B早盘涨超12% TROP2/HER3双抗ADC授权出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2656963586","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656963586?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 09:54","pubTimestamp":1785808440,"startTime":"0","endTime":"0","summary":"模拟交易客户端康宁杰瑞制药-B早盘涨超12%，截至发稿，股价上涨12.43%，现报8.32港元，成交额762.18万港元。康宁杰瑞生物制药宣布，其全资子公司江苏康宁杰瑞生物制药有限公司与Pathos AI， Inc．就康宁杰瑞自主研发的同类首创新药TROP2/HER3双特异性抗体偶联药物JSKN016达成授权许可协议。作为本次授权合作的一部分，康宁杰瑞获得Pathos授予的一份认股权证，有权认购Pathos的优先股股份，认购总价为6，250万美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-04/doc-inimchzt5433129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK4231","09966","BK4080","BK1574","ADC","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656248463","title":"中国生物制药(01177)：TQB2102“HER2双抗ADC”第三次被CDE纳入突破性治疗药物名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2656248463","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656248463?lang=zh_cn&edition=fundamental","pubTime":"2026-08-03 16:37","pubTimestamp":1785746238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，集团附属公司正大天晴药业集团股份有限公司自主研发的国家1类创新药TQB2102“HER2双抗 ADC”已被中国国家药品监督管理局药品审评中心纳入突破性治疗药物名单，用于在复发或转移性疾病阶段未接受过化疗的不可切除或转移性HER2低表达成人乳腺癌患者。这是继HER2阳性早期乳腺癌新辅助治疗、HER2 IHC 3+晚期结直肠癌之后，TQB2102获得的第三项突破性疗法认定，进一步印证了其在HER2表达实体瘤治疗领域的广泛应用潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4017","LU1223083913.SGD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","GDXJ","BK1191","LU1223082519.USD","LU1223082196.USD","BK1521","BK4231","BK1589","BK4080","NETL","HK0000165453.HKD","ADC","SGDM","SIL","CDE","BK1515","IE00BZ08YS42.EUR","01177","XME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656432314","title":"港股异动 | 百奥赛图-B(02315)午后涨超8% 近期与Whitehawk达成合作 旗下5款双抗ADC出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2656432314","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656432314?lang=zh_cn&edition=fundamental","pubTime":"2026-08-03 14:28","pubTimestamp":1785738520,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B午后涨超8%，截至发稿，涨6.28%，报53.3港元，成交额5248.07万港元。消息面上，近日，百奥赛图与Whitehawk Therapeutics达成一项全球战略合作协议，涵盖多个双特异性抗体偶联药物研发项目，双方将共同推进新一代治疗产品管线。据悉，Whitehawk将对百奥赛图提供的五款双特异性抗体进行评估，并有权选择将任何由此产生的ADC候选药物推进至其研发管线中，百奥赛图将获得一定数额的首付款及潜在里程碑付款。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","VXUS","ADC","688796","BK4080","BK0216","02315","BK4585","BK4231","NETL","KCAI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655280547","title":"李氏大药厂：专有ADC项目ZK2401新药临床试验申请获NMPA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2655280547","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655280547?lang=zh_cn&edition=fundamental","pubTime":"2026-07-30 22:20","pubTimestamp":1785421250,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","PSYK","BK4080","ADC","MDTX","NETL","IBBJ","IBBQ","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655712728","title":"科伦药业(002422.SZ)：TROP2 ADC芦康沙妥珠单抗(sac-TMT)新增适应症上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2655712728","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655712728?lang=zh_cn&edition=fundamental","pubTime":"2026-07-30 19:31","pubTimestamp":1785411100,"startTime":"0","endTime":"0","summary":"此前，芦康沙妥珠单抗用于一线治疗不可手术切除的局部晚期、复发或转移性PD-L1阴性TNBC已获NMPA授予突破性疗法认定。本次新增适应症上市申请亦已纳入优先审评审批程序，成为芦康沙妥珠单抗纳入该程序的第六项上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2148510915.USD","BK0239","ADC","002422","LU1064130708.USD","LU1934453819.USD","LU1979443071.USD","LU1064131003.USD","BK4231","NETL","BK4080","IPOS","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654395072","title":"Sonesitatug vedotin 在 CLDN18.2阳性晚期胃癌/胃食管结合部癌的二线及后线治疗中，显示出具有统计学显著性且重要临床意义的总生存期（OS）改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2654395072","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654395072?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 12:18","pubTimestamp":1785212280,"startTime":"0","endTime":"0","summary":"关于胃癌和胃食管结合部癌 胃癌是全球第五大常见癌症，也是癌症相关死亡的第五大原因。关键次要终点为二线及后线治疗人群的总生存期。CLDN18.2是一种存在于胃黏膜上皮中的蛋白，已被验证为肿瘤治疗领域的重要治疗靶点，尤其在胃肠道肿瘤中具有重要意义。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5013526_ZH13526_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5013526_ZH13526_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["CBOA","BTCW","FBTC","BETH","BTRN","YBTC","BTCL","NETL","CBOJ","BITU","ARKB","CBTO","BTCI","BITY","BFJL","CBXA","BITI","CBXY","BTCO","DEFI","IHC","AZN","MAXI","CBTJ","EAC","COAL","CBTA","BITX","BRRR","EZBC","BTC","BTCZ","HODL","HCC","CBTY","IBBQ","MNRS","BCCC","AZNH","PFS","BETE","CBXO","QBF","XBTY","BTFX","CBXJ","ADC","IBIT","SBIT","BITO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654224045","title":"科伦药业(002422.SZ)：科伦博泰新型双载荷ADC药物SKB565新药临床试验(IND)申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2654224045","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654224045?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 22:16","pubTimestamp":1785161788,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦药业 发布公告，公司近日获悉，公司控股子公司四川科伦博泰生物医药股份有限公司已收到国家药品监督管理局药品审评中心同意新型双载荷ADC药物SKB565新药临床试验申请的临床试验通知书，用于治疗晚期实体瘤。这是科伦博泰首个进入临床阶段的双载荷抗体偶联药物。据悉，SKB565是科伦博泰“ADC+IO”一体化开发策略的核心代表药物之一，基于科伦博泰专有的OptiDCTM平台开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002422","BK0060","BMED","IBBJ","BK4080","NETL","BK0239","PSYK","IND","LU1064130708.USD","LU1934453819.USD","MDTX","ADC","LU1064131003.USD","BK4231","IBBQ","LU2148510915.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654936970","title":"英派药业首个双载荷ADC成果落地：IMP3201被提名为临床前候选化合物","url":"https://stock-news.laohu8.com/highlight/detail?id=2654936970","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654936970?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 09:06","pubTimestamp":1785114360,"startTime":"0","endTime":"0","summary":"7月27日，英派药业（07630）发布公告，宣布IMP3201被提名为临床前候选化合物（PCC），这是基于公司自主研发的双载荷ADC平台的首个成果。IMP3201是一种靶向CEACAM5的双载荷ADC，采用优化的摩尔比搭载Exatecan及公司专有的ATR抑制剂。该化合物旨在治疗胃肠道恶性肿瘤，包括结直肠癌、胰腺癌、胃癌及食管鳞状细胞癌，以满足临床需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607273821349058.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607273821349058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NETL","BK4231","ADC","BK4080"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":99,"code":"91000000","status":"200"}]}}